Clinical Trial Update: Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cell Therapy for Patients With Hereditary Ataxia [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating safety and efficacy of Umbilical Cord Mesenchymal Stem Cell Therapy for hereditary ataxia; sponsored by Shenzhen Beike Bio-T…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Ataxia

Drugs mentioned

• Umbilical Cord Mesenchymal Stem Cell Therapy (umbilical cord-derived mesenchymal stem cells)

Snippet

Sponsor: Shenzhen Beike Bio-Technology Co., Ltd. | Conditions: Hereditary Ataxia | Phase 1, Phase 2 | Status: UNKNOWN